Documente Academic
Documente Profesional
Documente Cultură
PATIENT IDENTITY
Name
Gender Age Address Registration no. : Male : 52 years old : Sidrap : 554712
: Mr. N
ANAMNESIS
Chief complain : Chest pain History of present illness :
ANAMNESIS
Nausea ( - ), vomiting ( - ) Cough ( - ), Shortness of breath ( - ), Palpitation ( - )
ANAMNESIS
HISTORY OF PREVIOUS ILLNESS
History of heart disease ( - ) History of hypertension is ( - )
PHYSICAL EXAMINATION
General appearance : Moderate illness/well nourished/
composmentis
Vital Signs:
PHYSICAL EXAMINATION
Lung : Bronchovesicular, Rhonchi +/+ basal , Wheezing -/ Cor :
PHYSICAL EXAMINATION
Abdomen :
: flat and following breath movement : peristaltic sound (+) , normal : liver and spleen unpalpable : tympani, ascites (-)
ECG FINDINGS
ECG INTERPRETATION
Sinus Rhythm QRS Rate P Wave PR interval QRS complex Axis ST segment
: 90 x/minutes : 0.08
: 0.16
: 0.08 : +65 : ST elevation V3-V5, I, aVL,
ECG CONCLUSION
Rhythm Sinus Heart rate 90 x/ minute Anterolateral Myocardial Infarction
ECHOCARDIOGRAPHY
ECHOCARDIOGRAPHY
CONCLUSION :
LV systolic & dystolic dysfunction, EF 46% Dilated LA, LVH (+) MV prolaps Hypokinetic inferolateral septal PH-TR severe
CHEST X-RAY
CONCLUSION :
LABORATORIUM FINDINGS
Complete blood count
WBC
RBC HGB HCT PLT
Blood chemistry
Blood glucose
Ureum Creatinine
:17.93x103/ul
: 5.95X10^6/ul : 16.6 gr/dl : 51.9% : 271 x 103/l : 4118 U/L : 319 U/L : >2.0
:138
: 26 mg/dl : 1.0 mg/dl
SGOT
SGPT
: 407 u/dl
: 87 u/ dl
Enzymes
CK CK-MB Trop T
HDL
LDL Trigliseride
: 137 u/dl
: 44 u/dl : 209 u/dl
DIAGNOSIS
Anterolateral wall STEMI onset >12 hours, Killip II
INITIAL MANAGEMENT
Bed rest O2 2-4 lpm ( via nasal canule ) IVFD NaCl 0,9% 10 dpm Cedocard 10mg/ min/iv/SP Amiodarone 600mg/24 hrs/SP
Arixtra 2,5mg/24hrs/SC
Fargoxin 0,5mg/iv/bolus(slowly) CPG 75 mg 0-1-0/ oral Aspilet 80 mg 1-0-0/oral
ADVISE
Coronary Angiography
DISCUSSION
DEFINITION
Myocardial infarction (MI) rapid
development of myocardial necrosis caused by a critical imbalance between the oxygen supply and demand of the myocardium.
This usually results from plaque
rupture with thrombus formation in a coronary vessels, resulting in an acute reduction of blood supply to a portion of the myocardium.
PaTHOPHYSIOLOGY
Occurs when coronary
blood flow decreases abruptly after a thrombotic occlusion of a coronary artery previously affected by atherosclerosis. In most cases, infarction occurs when an atherosclerotic plaque fissures, ruptures, or ulcerates.
CLASSIFICATION
ACS describe a group of conditions resulting from acute myocardial ischemia (insufficient blood flow to heart muscle) ranging from unstable angina to myocardial infarction.
Risk factors
Non- Modifiable
Gender and Age Men, increased risk after age 45
Modifiable
Smoking Hypertension Diabetis Mellitus Dyslipidemia Obesity Lack of physical activity
3.
Clinical history of ischaemic type chest pain lasting >20 minutes Changes in serial ECG tracings Rise of serum cardiac biomarkers such as creatinine kinase-MB fraction and troponin-T
CLINICAL FEATURES
Chest pain, >30 minutes Usually tight, crushing, and band
like Location in retrosternal May radiate to left arm, throat, and jaw Associated features including palpitation, sweating, breathlessness, and nausea.
over area of damage ST depression in leads opposite infarction Pathological Q waves Reduced R waves Inverted T waves
Cardiac biomarkers
Diagnose DIAGNOSIS
Signs of myocardial ischemia
ECG
Yes
ST segmen elevation ?
No Lab Biochemical cardiac markers ? No Yes
Unstable Angina
Therapy
Manage chest pain and bad feeling/stress
Oxygen 4 lpm ( increase the supply of oxygen) Give nitrat oral/IV (for the angina) Give antiplatelet Give morphine or petidine (for infark pain) Give diazepam 2/5mg (for make the patient relax)
Therapy
Hemodanamic stabilization Fasting first 8 hours after attack then eat soft food Give laxadyn Bed rest until 24 hours free from angina Blood pressure and heart rate is control with
-Beta blocker
-Ace inhibitor
Therapy
Myocardiac reprofusion as soon as possible Thrombolitic - streptokinase and t-PA
PROGNOSIS
KILLIP CLASSIFICATION
Class I II
Description No clinical signs of heart failure Rales or crackles in the lungs, an S3, and elevated jugular venous pressure Acute pulmonary edema Cardiogenic shock or hypotension (systolic BP < 90 mmHg), and evidence of peripheral vasoconstriction
III IV
30 - 40 60 80
COMPLICATION
Odds of death by 30D* 0.1 (0.1-0.2) 0.3 (0.2-0.3) 0.4 (0.3-0.5) 0.7 (0.6-0.9) 1.2 (1.0-1.5) 2.2 (1.9-2.6) 3.0 (2.5-3.6) 4.8 (3.8-6.1) 5.8 (4.2-7.8) 8.8 (6.3-12)
0 or 1
5%
Low
2
3 4
8%
13 % 20 % Intermedi ate
5
6 or 7
26 %
41 %
High